Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BYFrontiers in Oncology

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

Related

  1. Editorial: Green technologies and bioactive profiling in aromatic and medicinal plants
    Hanen Najjaa, Patricia Rijo
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPlant biologyCrossref
  2. Editorial: Potential therapeutic targets in alcohol use disorder: insights from recent preclinical studies
    Ilaria Morella, Priscila Vázquez-León, Valentina Vengeliene +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textNeuroscienceCrossref
  3. Editorial: The breast cancer tumor microenvironment: from model systems to clinical translation
    Ali Mussa, Rohimah Mohamud, Mohammad AI Al-Hatamleh
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  4. Editorial: Targeted therapies in gastric cancer: molecular signatures and immune microenvironment insights
    Alessandro Mangogna, Laura Mariuzzi, Giuseppe Aprile +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  5. Editorial: Advancing plant histopathology: unraveling plant-pathogen interactions and disease resistance mechanisms
    João Paulo Rodrigues Marques, Mariana Patanita
    Frontiers in Plant SciencePeer-reviewedCC BY 4.0Plant biologyCrossref
BibTeX
@article{adriani2026editorial,
  title = {{Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance}},
  author = {Giulia Adriani and Paola Cappello and Sara Lovisa},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = oct,
  doi = {10.3389/fonc.2023.1289756},
  url = {https://hal.science/hal-05776440v1},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance
AU  - Giulia Adriani
AU  - Paola Cappello
AU  - Sara Lovisa
PY  - 2026
DA  - 2026/10/03
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2023.1289756
UR  - https://hal.science/hal-05776440v1
SN  - 2234-943X
ER  -